APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biologics Clinical Manufacturing CDMO Service

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Biologics Clinical Manufacturing CDMO Service Industry Growth and Trends Forecast to 2032

11 April 2026114 pages

Choose your research edition.

Industry ResearchBiologics Clinical Manufacturing CDMO Service Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Biologics Clinical Manufacturing CDMO Service Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Biologics Clinical Manufacturing CDMO Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biologics Clinical Manufacturing CDMO Service Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Biologics Clinical Manufacturing CDMO Service Market Analysis and Forecast 2026-2032241 pages · $4,950 USD

Market perspective

According to APO Research, the global Biologics Clinical Manufacturing CDMO Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Biologics Clinical Manufacturing CDMO Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Biologics Clinical Manufacturing CDMO Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biologics Clinical Manufacturing CDMO Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Biologics Clinical Manufacturing CDMO Service market include Thermo Fisher Scientific, Lonza, Intertek, Charles River Laboratories, Bio-Rad, Element, ProPharma, Ascendia and Minaris Regenerative Medicine, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Biologics Clinical Manufacturing CDMO Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Biologics Clinical Manufacturing CDMO Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Biologics Clinical Manufacturing CDMO Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Biologics Clinical Manufacturing CDMO Service.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Biologics Clinical Manufacturing CDMO Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Biologics Clinical Manufacturing CDMO Service Market by Company

Thermo Fisher Scientific

Lonza

Intertek

Charles River Laboratories

Bio-Rad

Element

ProPharma

Ascendia

Minaris Regenerative Medicine

TriLink BioTechnologies

Oakwood Labs

PiramalPharma Solutions

Boehringer-Ingelheim

Wuxi Apptec

Pharmaron Beijing

Asymchem Laboratories (Tianjin)

Porton

SEQENS

Biologics Clinical Manufacturing CDMO Service Segment by Type

Traditional API CDMO

Highly Potent API CDMO

Biologics Clinical Manufacturing CDMO Service Segment by Application

Big Pharmaceutical Companies

Small and Medium Pharmaceutical Companies

Biologics Clinical Manufacturing CDMO Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biologics Clinical Manufacturing CDMO Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biologics Clinical Manufacturing CDMO Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biologics Clinical Manufacturing CDMO Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Biologics Clinical Manufacturing CDMO Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Biologics Clinical Manufacturing CDMO Service Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Biologics Clinical Manufacturing CDMO Service Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Biologics Clinical Manufacturing CDMO Service Market Share by Region (2021-2026) Table 4. Global Biologics Clinical Manufacturing CDMO Service Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Biologics Clinical Manufacturing CDMO Service Market Share by Region (2027-2032) Table 6. Global Biologics Clinical Manufacturing CDMO Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Biologics Clinical Manufacturing CDMO Service Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Biologics Clinical Manufacturing CDMO Service Market Size Share by Type (2021-2026) Table 9. Global Biologics Clinical Manufacturing CDMO Service Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Biologics Clinical Manufacturing CDMO Service Market Size Share Forecasted by Type (2027-2032) Table 11. North America Biologics Clinical Manufacturing CDMO Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Biologics Clinical Manufacturing CDMO Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Biologics Clinical Manufacturing CDMO Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Biologics Clinical Manufacturing CDMO Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Biologics Clinical Manufacturing CDMO Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Biologics Clinical Manufacturing CDMO Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Biologics Clinical Manufacturing CDMO Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Biologics Clinical Manufacturing CDMO Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Biologics Clinical Manufacturing CDMO Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Biologics Clinical Manufacturing CDMO Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Biologics Clinical Manufacturing CDMO Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Biologics Clinical Manufacturing CDMO Service Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Biologics Clinical Manufacturing CDMO Service Market Size Share by Application (2021-2026) Table 24. Global Biologics Clinical Manufacturing CDMO Service Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Biologics Clinical Manufacturing CDMO Service Market Size Share Forecasted by Application (2027-2032) Table 26. North America Biologics Clinical Manufacturing CDMO Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Biologics Clinical Manufacturing CDMO Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Biologics Clinical Manufacturing CDMO Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Biologics Clinical Manufacturing CDMO Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Biologics Clinical Manufacturing CDMO Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Biologics Clinical Manufacturing CDMO Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Biologics Clinical Manufacturing CDMO Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Biologics Clinical Manufacturing CDMO Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Biologics Clinical Manufacturing CDMO Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Biologics Clinical Manufacturing CDMO Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Biologics Clinical Manufacturing CDMO Service Industry Trends Table 37. Biologics Clinical Manufacturing CDMO Service Industry Drivers Table 38. Biologics Clinical Manufacturing CDMO Service Industry Opportunities and Challenges Table 39. Biologics Clinical Manufacturing CDMO Service Industry Restraints Table 40. Global Biologics Clinical Manufacturing CDMO Service Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Biologics Clinical Manufacturing CDMO Service Revenue Market Share by Company (2021-2026) Table 42. Global Biologics Clinical Manufacturing CDMO Service Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Biologics Clinical Manufacturing CDMO Service Key Company Headquarters & Area Served Table 44. Global Biologics Clinical Manufacturing CDMO Service Company, Product Type & Application Table 45. Global Biologics Clinical Manufacturing CDMO Service Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Biologics Clinical Manufacturing CDMO Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Thermo Fisher Scientific Company Information Table 49. Thermo Fisher Scientific Business Overview Table 50. Thermo Fisher Scientific Biologics Clinical Manufacturing CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Thermo Fisher Scientific Biologics Clinical Manufacturing CDMO Service Product Portfolio Table 52. Thermo Fisher Scientific Recent Development Table 53. Lonza Company Information Table 54. Lonza Business Overview Table 55. Lonza Biologics Clinical Manufacturing CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Lonza Biologics Clinical Manufacturing CDMO Service Product Portfolio Table 57. Lonza Recent Development Table 58. Intertek Company Information Table 59. Intertek Business Overview Table 60. Intertek Biologics Clinical Manufacturing CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Intertek Biologics Clinical Manufacturing CDMO Service Product Portfolio Table 62. Intertek Recent Development Table 63. Charles River Laboratories Company Information Table 64. Charles River Laboratories Business Overview Table 65. Charles River Laboratories Biologics Clinical Manufacturing CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Charles River Laboratories Biologics Clinical Manufacturing CDMO Service Product Portfolio Table 67. Charles River Laboratories Recent Development Table 68. Bio-Rad Company Information Table 69. Bio-Rad Business Overview Table 70. Bio-Rad Biologics Clinical Manufacturing CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Bio-Rad Biologics Clinical Manufacturing CDMO Service Product Portfolio Table 72. Bio-Rad Recent Development Table 73. Element Company Information Table 74. Element Business Overview Table 75. Element Biologics Clinical Manufacturing CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Element Biologics Clinical Manufacturing CDMO Service Product Portfolio Table 77. Element Recent Development Table 78. ProPharma Company Information Table 79. ProPharma Business Overview Table 80. ProPharma Biologics Clinical Manufacturing CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. ProPharma Biologics Clinical Manufacturing CDMO Service Product Portfolio Table 82. ProPharma Recent Development Table 83. Ascendia Company Information Table 84. Ascendia Business Overview Table 85. Ascendia Biologics Clinical Manufacturing CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Ascendia Biologics Clinical Manufacturing CDMO Service Product Portfolio Table 87. Ascendia Recent Development Table 88. Minaris Regenerative Medicine Company Information Table 89. Minaris Regenerative Medicine Business Overview Table 90. Minaris Regenerative Medicine Biologics Clinical Manufacturing CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Minaris Regenerative Medicine Biologics Clinical Manufacturing CDMO Service Product Portfolio Table 92. Minaris Regenerative Medicine Recent Development Table 93. TriLink BioTechnologies Company Information Table 94. TriLink BioTechnologies Business Overview Table 95. TriLink BioTechnologies Biologics Clinical Manufacturing CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. TriLink BioTechnologies Biologics Clinical Manufacturing CDMO Service Product Portfolio Table 97. TriLink BioTechnologies Recent Development Table 98. Oakwood Labs Company Information Table 99. Oakwood Labs Business Overview Table 100. Oakwood Labs Biologics Clinical Manufacturing CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Oakwood Labs Biologics Clinical Manufacturing CDMO Service Product Portfolio Table 102. Oakwood Labs Recent Development Table 103. PiramalPharma Solutions Company Information Table 104. PiramalPharma Solutions Business Overview Table 105. PiramalPharma Solutions Biologics Clinical Manufacturing CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. PiramalPharma Solutions Biologics Clinical Manufacturing CDMO Service Product Portfolio Table 107. PiramalPharma Solutions Recent Development Table 108. Boehringer-Ingelheim Company Information Table 109. Boehringer-Ingelheim Business Overview Table 110. Boehringer-Ingelheim Biologics Clinical Manufacturing CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Boehringer-Ingelheim Biologics Clinical Manufacturing CDMO Service Product Portfolio Table 112. Boehringer-Ingelheim Recent Development Table 113. Wuxi Apptec Company Information Table 114. Wuxi Apptec Business Overview Table 115. Wuxi Apptec Biologics Clinical Manufacturing CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Wuxi Apptec Biologics Clinical Manufacturing CDMO Service Product Portfolio Table 117. Wuxi Apptec Recent Development Table 118. Pharmaron Beijing Company Information Table 119. Pharmaron Beijing Business Overview Table 120. Pharmaron Beijing Biologics Clinical Manufacturing CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Pharmaron Beijing Biologics Clinical Manufacturing CDMO Service Product Portfolio Table 122. Pharmaron Beijing Recent Development Table 123. Asymchem Laboratories (Tianjin) Company Information Table 124. Asymchem Laboratories (Tianjin) Business Overview Table 125. Asymchem Laboratories (Tianjin) Biologics Clinical Manufacturing CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Asymchem Laboratories (Tianjin) Biologics Clinical Manufacturing CDMO Service Product Portfolio Table 127. Asymchem Laboratories (Tianjin) Recent Development Table 128. Porton Company Information Table 129. Porton Business Overview Table 130. Porton Biologics Clinical Manufacturing CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Porton Biologics Clinical Manufacturing CDMO Service Product Portfolio Table 132. Porton Recent Development Table 133. SEQENS Company Information Table 134. SEQENS Business Overview Table 135. SEQENS Biologics Clinical Manufacturing CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. SEQENS Biologics Clinical Manufacturing CDMO Service Product Portfolio Table 137. SEQENS Recent Development Table 138. North America Biologics Clinical Manufacturing CDMO Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. North America Biologics Clinical Manufacturing CDMO Service Market Size by Country (2021-2026) & (US$ Million) Table 140. North America Biologics Clinical Manufacturing CDMO Service Market Share by Country (2021-2026) Table 141. North America Biologics Clinical Manufacturing CDMO Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. North America Biologics Clinical Manufacturing CDMO Service Market Share Forecast by Country (2027-2032) Table 143. Europe Biologics Clinical Manufacturing CDMO Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Europe Biologics Clinical Manufacturing CDMO Service Market Size by Country (2021-2026) & (US$ Million) Table 145. Europe Biologics Clinical Manufacturing CDMO Service Market Share by Country (2021-2026) Table 146. Europe Biologics Clinical Manufacturing CDMO Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Europe Biologics Clinical Manufacturing CDMO Service Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Biologics Clinical Manufacturing CDMO Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Biologics Clinical Manufacturing CDMO Service Market Size by Country (2021-2026) & (US$ Million) Table 150. Asia-Pacific Biologics Clinical Manufacturing CDMO Service Market Share by Country (2021-2026) Table 151. Asia-Pacific Biologics Clinical Manufacturing CDMO Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Asia-Pacific Biologics Clinical Manufacturing CDMO Service Market Share Forecast by Country (2027-2032) Table 153. Latin America Biologics Clinical Manufacturing CDMO Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Biologics Clinical Manufacturing CDMO Service Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Biologics Clinical Manufacturing CDMO Service Market Share by Country (2021-2026) Table 156. Latin America Biologics Clinical Manufacturing CDMO Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Biologics Clinical Manufacturing CDMO Service Market Share Forecast by Country (2027-2032) Table 158. Middle East & Africa Biologics Clinical Manufacturing CDMO Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Middle East & Africa Biologics Clinical Manufacturing CDMO Service Market Size by Country (2021-2026) & (US$ Million) Table 160. Middle East & Africa Biologics Clinical Manufacturing CDMO Service Market Share by Country (2021-2026) Table 161. Middle East & Africa Biologics Clinical Manufacturing CDMO Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Middle East & Africa Biologics Clinical Manufacturing CDMO Service Market Share Forecast by Country (2027-2032) Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Biologics Clinical Manufacturing CDMO Service Product Image Figure 3. Global Biologics Clinical Manufacturing CDMO Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Biologics Clinical Manufacturing CDMO Service Market Size (2021-2032) & (US$ Million) Figure 5. Global Biologics Clinical Manufacturing CDMO Service Market Share by Region: 2025 VS 2032 Figure 6. Global Biologics Clinical Manufacturing CDMO Service Market Share by Region (2021-2032) Figure 7. North America Biologics Clinical Manufacturing CDMO Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Biologics Clinical Manufacturing CDMO Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Biologics Clinical Manufacturing CDMO Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Biologics Clinical Manufacturing CDMO Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Biologics Clinical Manufacturing CDMO Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Traditional API CDMO Image Figure 13. Global Traditional API CDMO Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Highly Potent API CDMO Image Figure 15. Global Highly Potent API CDMO Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Biologics Clinical Manufacturing CDMO Service Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Biologics Clinical Manufacturing CDMO Service Market Share by Type 2025 VS 2032 Figure 18. North America Biologics Clinical Manufacturing CDMO Service Market Size Share by Type (2021-2032) Figure 19. Europe Biologics Clinical Manufacturing CDMO Service Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Biologics Clinical Manufacturing CDMO Service Market Size Share by Type (2021-2032) Figure 21. Latin America Biologics Clinical Manufacturing CDMO Service Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Biologics Clinical Manufacturing CDMO Service Market Size Share by Type (2021-2032) Figure 23. Big Pharmaceutical Companies Image Figure 24. Global Big Pharmaceutical Companies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Small and Medium Pharmaceutical Companies Image Figure 26. Global Small and Medium Pharmaceutical Companies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Global Biologics Clinical Manufacturing CDMO Service Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Biologics Clinical Manufacturing CDMO Service Market Share by Application 2025 VS 2032 Figure 29. North America Biologics Clinical Manufacturing CDMO Service Market Size Share by Application (2021-2032) Figure 30. Europe Biologics Clinical Manufacturing CDMO Service Market Size Share by Application (2021-2032) Figure 31. Asia-Pacific Biologics Clinical Manufacturing CDMO Service Market Size Share by Application (2021-2032) Figure 32. Latin America Biologics Clinical Manufacturing CDMO Service Market Size Share by Application (2021-2032) Figure 33. Middle East and Africa Biologics Clinical Manufacturing CDMO Service Market Size Share by Application (2021-2032) Figure 34. Global Top 5 and 10 Biologics Clinical Manufacturing CDMO Service Players Market Share by Revenue in 2025 Figure 35. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 36. North America Biologics Clinical Manufacturing CDMO Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 37. North America Biologics Clinical Manufacturing CDMO Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 38. North America Biologics Clinical Manufacturing CDMO Service Market Share by Country (2021-2032) Figure 39. Europe Biologics Clinical Manufacturing CDMO Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 40. Europe Biologics Clinical Manufacturing CDMO Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 41. Europe Biologics Clinical Manufacturing CDMO Service Market Share by Country (2021-2032) Figure 42. Asia-Pacific Biologics Clinical Manufacturing CDMO Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. Asia-Pacific Biologics Clinical Manufacturing CDMO Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. Asia-Pacific Biologics Clinical Manufacturing CDMO Service Market Share by Country (2021-2032) Figure 45. Latin America Biologics Clinical Manufacturing CDMO Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Latin America Biologics Clinical Manufacturing CDMO Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Latin America Biologics Clinical Manufacturing CDMO Service Market Share by Country (2021-2032) Figure 48. Middle East & Africa Biologics Clinical Manufacturing CDMO Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Middle East & Africa Biologics Clinical Manufacturing CDMO Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Middle East & Africa Biologics Clinical Manufacturing CDMO Service Market Share by Country (2021-2032) Figure 51. Years Considered Figure 52. Research Process Figure 53. Key Executives Interviewed

Scope & coverage.

Types
  • Traditional API CDMO
  • Highly Potent API CDMO
Applications
  • Big Pharmaceutical Companies
  • Small and Medium Pharmaceutical Companies
Companies covered
  • Thermo Fisher Scientific
  • Lonza
  • Intertek
  • Charles River Laboratories
  • Bio-Rad
  • Element
  • ProPharma
  • Ascendia
  • Minaris Regenerative Medicine
  • TriLink BioTechnologies
  • Oakwood Labs
  • PiramalPharma Solutions
  • Boehringer-Ingelheim
  • Wuxi Apptec
  • Pharmaron Beijing
  • Asymchem Laboratories (Tianjin)
  • Porton
  • SEQENS

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Biologics Clinical Manufacturing CDMO Service Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Biologics Clinical Manufacturing CDMO Service Market Size by Region (2021-2032)
  5. 1.4.1 Global Biologics Clinical Manufacturing CDMO Service Market Size by Region (2021-2026)
  6. 1.4.2 Global Biologics Clinical Manufacturing CDMO Service Market Size by Region (2027-2032)
  7. 1.5 Key Regions Biologics Clinical Manufacturing CDMO Service Market Size (2021-2032)
  8. 1.5.1 North America Biologics Clinical Manufacturing CDMO Service Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Biologics Clinical Manufacturing CDMO Service Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Biologics Clinical Manufacturing CDMO Service Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Biologics Clinical Manufacturing CDMO Service Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Biologics Clinical Manufacturing CDMO Service Market Size Growth Rate (2021-2032)
2 Biologics Clinical Manufacturing CDMO Service Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Traditional API CDMO
  3. 2.1.2 Highly Potent API CDMO
  4. 2.2 Global Biologics Clinical Manufacturing CDMO Service Market Size by Type
  5. 2.2.1 Global Biologics Clinical Manufacturing CDMO Service Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Biologics Clinical Manufacturing CDMO Service Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Biologics Clinical Manufacturing CDMO Service Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Biologics Clinical Manufacturing CDMO Service Market Size by Regions
  9. 2.3.1 North America Biologics Clinical Manufacturing CDMO Service Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Biologics Clinical Manufacturing CDMO Service Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Biologics Clinical Manufacturing CDMO Service Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Biologics Clinical Manufacturing CDMO Service Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Biologics Clinical Manufacturing CDMO Service Market Size Breakdown by Type (2021-2026)
3 Biologics Clinical Manufacturing CDMO Service Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Big Pharmaceutical Companies
  3. 3.1.2 Small and Medium Pharmaceutical Companies
  4. 3.2 Global Biologics Clinical Manufacturing CDMO Service Market Size by Application
  5. 3.2.1 Global Biologics Clinical Manufacturing CDMO Service Market Size Overview by Application (2021-2032)
  6. 3.2.2 Global Biologics Clinical Manufacturing CDMO Service Historic Market Size Review by Application (2021-2026)
  7. 3.2.3 Global Biologics Clinical Manufacturing CDMO Service Market Size Forecasted by Application (2027-2032)
  8. 3.3 Global Biologics Clinical Manufacturing CDMO Service Market Size by Regions
  9. 3.3.1 North America Biologics Clinical Manufacturing CDMO Service Market Size Breakdown by Application (2021-2026)
  10. 3.3.2 Europe Biologics Clinical Manufacturing CDMO Service Market Size Breakdown by Application (2021-2026)
  11. 3.3.3 Asia-Pacific Biologics Clinical Manufacturing CDMO Service Market Size Breakdown by Application (2021-2026)
  12. 3.3.4 South America Biologics Clinical Manufacturing CDMO Service Market Size Breakdown by Application (2021-2026)
  13. 3.3.5 Middle East and Africa Biologics Clinical Manufacturing CDMO Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Biologics Clinical Manufacturing CDMO Service Industry Trends
  2. 4.2 Biologics Clinical Manufacturing CDMO Service Industry Drivers
  3. 4.3 Biologics Clinical Manufacturing CDMO Service Industry Opportunities and Challenges
  4. 4.4 Biologics Clinical Manufacturing CDMO Service Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Biologics Clinical Manufacturing CDMO Service Revenue (2021-2026)
  2. 5.2 Global Biologics Clinical Manufacturing CDMO Service Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Biologics Clinical Manufacturing CDMO Service Key Company Headquarters & Area Served
  4. 5.4 Global Biologics Clinical Manufacturing CDMO Service Company, Product Type & Application
  5. 5.5 Global Biologics Clinical Manufacturing CDMO Service Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Biologics Clinical Manufacturing CDMO Service Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Biologics Clinical Manufacturing CDMO Service Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Biologics Clinical Manufacturing CDMO Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Thermo Fisher Scientific
  2. 6.1.1 Thermo Fisher Scientific Company Information
  3. 6.1.2 Thermo Fisher Scientific Business Overview
  4. 6.1.3 Thermo Fisher Scientific Biologics Clinical Manufacturing CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Thermo Fisher Scientific Biologics Clinical Manufacturing CDMO Service Product Portfolio
  6. 6.1.5 Thermo Fisher Scientific Recent Developments
  7. 6.2 Lonza
  8. 6.2.1 Lonza Company Information
  9. 6.2.2 Lonza Business Overview
  10. 6.2.3 Lonza Biologics Clinical Manufacturing CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Lonza Biologics Clinical Manufacturing CDMO Service Product Portfolio
  12. 6.2.5 Lonza Recent Developments
  13. 6.3 Intertek
  14. 6.3.1 Intertek Company Information
  15. 6.3.2 Intertek Business Overview
  16. 6.3.3 Intertek Biologics Clinical Manufacturing CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Intertek Biologics Clinical Manufacturing CDMO Service Product Portfolio
  18. 6.3.5 Intertek Recent Developments
  19. 6.4 Charles River Laboratories
  20. 6.4.1 Charles River Laboratories Company Information
  21. 6.4.2 Charles River Laboratories Business Overview
  22. 6.4.3 Charles River Laboratories Biologics Clinical Manufacturing CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Charles River Laboratories Biologics Clinical Manufacturing CDMO Service Product Portfolio
  24. 6.4.5 Charles River Laboratories Recent Developments
  25. 6.5 Bio-Rad
  26. 6.5.1 Bio-Rad Company Information
  27. 6.5.2 Bio-Rad Business Overview
  28. 6.5.3 Bio-Rad Biologics Clinical Manufacturing CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Bio-Rad Biologics Clinical Manufacturing CDMO Service Product Portfolio
  30. 6.5.5 Bio-Rad Recent Developments
  31. 6.6 Element
  32. 6.6.1 Element Company Information
  33. 6.6.2 Element Business Overview
  34. 6.6.3 Element Biologics Clinical Manufacturing CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Element Biologics Clinical Manufacturing CDMO Service Product Portfolio
  36. 6.6.5 Element Recent Developments
  37. 6.7 ProPharma
  38. 6.7.1 ProPharma Company Information
  39. 6.7.2 ProPharma Business Overview
  40. 6.7.3 ProPharma Biologics Clinical Manufacturing CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 ProPharma Biologics Clinical Manufacturing CDMO Service Product Portfolio
  42. 6.7.5 ProPharma Recent Developments
  43. 6.8 Ascendia
  44. 6.8.1 Ascendia Company Information
  45. 6.8.2 Ascendia Business Overview
  46. 6.8.3 Ascendia Biologics Clinical Manufacturing CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Ascendia Biologics Clinical Manufacturing CDMO Service Product Portfolio
  48. 6.8.5 Ascendia Recent Developments
  49. 6.9 Minaris Regenerative Medicine
  50. 6.9.1 Minaris Regenerative Medicine Company Information
  51. 6.9.2 Minaris Regenerative Medicine Business Overview
  52. 6.9.3 Minaris Regenerative Medicine Biologics Clinical Manufacturing CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Minaris Regenerative Medicine Biologics Clinical Manufacturing CDMO Service Product Portfolio
  54. 6.9.5 Minaris Regenerative Medicine Recent Developments
  55. 6.10 TriLink BioTechnologies
  56. 6.10.1 TriLink BioTechnologies Company Information
  57. 6.10.2 TriLink BioTechnologies Business Overview
  58. 6.10.3 TriLink BioTechnologies Biologics Clinical Manufacturing CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 TriLink BioTechnologies Biologics Clinical Manufacturing CDMO Service Product Portfolio
  60. 6.10.5 TriLink BioTechnologies Recent Developments
  61. 6.11 Oakwood Labs
  62. 6.11.1 Oakwood Labs Company Information
  63. 6.11.2 Oakwood Labs Business Overview
  64. 6.11.3 Oakwood Labs Biologics Clinical Manufacturing CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Oakwood Labs Biologics Clinical Manufacturing CDMO Service Product Portfolio
  66. 6.11.5 Oakwood Labs Recent Developments
  67. 6.12 PiramalPharma Solutions
  68. 6.12.1 PiramalPharma Solutions Company Information
  69. 6.12.2 PiramalPharma Solutions Business Overview
  70. 6.12.3 PiramalPharma Solutions Biologics Clinical Manufacturing CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 PiramalPharma Solutions Biologics Clinical Manufacturing CDMO Service Product Portfolio
  72. 6.12.5 PiramalPharma Solutions Recent Developments
  73. 6.13 Boehringer-Ingelheim
  74. 6.13.1 Boehringer-Ingelheim Company Information
  75. 6.13.2 Boehringer-Ingelheim Business Overview
  76. 6.13.3 Boehringer-Ingelheim Biologics Clinical Manufacturing CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Boehringer-Ingelheim Biologics Clinical Manufacturing CDMO Service Product Portfolio
  78. 6.13.5 Boehringer-Ingelheim Recent Developments
  79. 6.14 Wuxi Apptec
  80. 6.14.1 Wuxi Apptec Company Information
  81. 6.14.2 Wuxi Apptec Business Overview
  82. 6.14.3 Wuxi Apptec Biologics Clinical Manufacturing CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Wuxi Apptec Biologics Clinical Manufacturing CDMO Service Product Portfolio
  84. 6.14.5 Wuxi Apptec Recent Developments
  85. 6.15 Pharmaron Beijing
  86. 6.15.1 Pharmaron Beijing Company Information
  87. 6.15.2 Pharmaron Beijing Business Overview
  88. 6.15.3 Pharmaron Beijing Biologics Clinical Manufacturing CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Pharmaron Beijing Biologics Clinical Manufacturing CDMO Service Product Portfolio
  90. 6.15.5 Pharmaron Beijing Recent Developments
  91. 6.16 Asymchem Laboratories (Tianjin)
  92. 6.16.1 Asymchem Laboratories (Tianjin) Company Information
  93. 6.16.2 Asymchem Laboratories (Tianjin) Business Overview
  94. 6.16.3 Asymchem Laboratories (Tianjin) Biologics Clinical Manufacturing CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Asymchem Laboratories (Tianjin) Biologics Clinical Manufacturing CDMO Service Product Portfolio
  96. 6.16.5 Asymchem Laboratories (Tianjin) Recent Developments
  97. 6.17 Porton
  98. 6.17.1 Porton Company Information
  99. 6.17.2 Porton Business Overview
  100. 6.17.3 Porton Biologics Clinical Manufacturing CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Porton Biologics Clinical Manufacturing CDMO Service Product Portfolio
  102. 6.17.5 Porton Recent Developments
  103. 6.18 SEQENS
  104. 6.18.1 SEQENS Company Information
  105. 6.18.2 SEQENS Business Overview
  106. 6.18.3 SEQENS Biologics Clinical Manufacturing CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 SEQENS Biologics Clinical Manufacturing CDMO Service Product Portfolio
  108. 6.18.5 SEQENS Recent Developments
7 North America
  1. 7.1 North America Biologics Clinical Manufacturing CDMO Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Biologics Clinical Manufacturing CDMO Service Market Size by Country (2021-2026)
  3. 7.3 North America Biologics Clinical Manufacturing CDMO Service Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Biologics Clinical Manufacturing CDMO Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Biologics Clinical Manufacturing CDMO Service Market Size by Country (2021-2026)
  3. 8.3 Europe Biologics Clinical Manufacturing CDMO Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Biologics Clinical Manufacturing CDMO Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Biologics Clinical Manufacturing CDMO Service Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Biologics Clinical Manufacturing CDMO Service Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Biologics Clinical Manufacturing CDMO Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Biologics Clinical Manufacturing CDMO Service Market Size by Country (2021-2026)
  3. 10.3 South America Biologics Clinical Manufacturing CDMO Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Biologics Clinical Manufacturing CDMO Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Biologics Clinical Manufacturing CDMO Service Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Biologics Clinical Manufacturing CDMO Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst